The Generics segment is the cornerstone of Amneal's operations, focusing on the development, manufacturing, and commercialization of a wide array of pharmaceutical products. This includes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals. Research and development efforts are geared towards creating high-quality, affordable alternatives to branded medications across various therapeutic categories. The segment leverages advanced formulation technologies and efficient manufacturing processes to ensure product quality and cost-effectiveness. By providing accessible generic medicines, this segment significantly impacts patient access to essential treatments and contributes to healthcare cost savings. Future opportunities include expanding the portfolio of complex generics and penetrating new markets.

The Specialty segment is dedicated to the development, promotion, distribution, and sale of branded pharmaceutical products, with a focus on central nervous system disorders, endocrinology, and parasitic infections. This segment involves rigorous clinical trials and regulatory processes to bring innovative treatments to market. Key products include Emverm for parasitic infections, Rytary for Parkinson's disease, and Unithroid for hypothyroidism. The segment's R&D activities are centered on identifying unmet medical needs and developing targeted therapies to improve patient outcomes. By focusing on specialized therapeutic areas, Amneal aims to provide patients with advanced treatment options and enhance their quality of life. Future growth potential lies in expanding the specialty product portfolio and exploring new therapeutic indications.

The AvKARE segment operates as a critical provider of pharmaceuticals, medical and surgical products, and services, primarily serving governmental agencies, including the Department of Defense and the Department of Veterans Affairs. This segment is also involved in the wholesale distribution of bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names, as well as medical and surgical products. AvKARE ensures the reliable supply of essential healthcare products to government entities and healthcare institutions. The segment's activities include packaging and wholesale distribution of pharmaceuticals and vitamins to retail and institutional customers. By focusing on government contracts and wholesale distribution, AvKARE plays a vital role in supporting public health initiatives and ensuring access to affordable medicines for veterans and other government beneficiaries. Future opportunities include expanding its product offerings and strengthening its relationships with government agencies.